Loading clinical trials...
Loading clinical trials...
HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID): a National Platform Trial
Conditions
Interventions
Apixaban
Atorvastatin
Locations
1
United Kingdom
Addenbrookes Hospital
Cambridge, United Kingdom
Start Date
May 19, 2021
Primary Completion Date
January 31, 2024
Completion Date
January 31, 2024
Last Updated
July 23, 2021
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions